Uncategorized

How Brand-Name Drug Companies Delay Generic Competition: Product Hopping, Patent Thickets, and Market Exclusivity Tactics Explained

Brand-name drug companies dont just protect innovation. They often manage timestretching it, segmenting it, and monetizing ituntil generic competition cant arrive fast enough.
Thats the core story behind product hopping, patent thickets, and market e…

How Brand-Name Drug Companies Delay Generic Competition: Product Hopping, Patent Thickets, and Market Exclusivity Tactics Explained Read Post »

Biotechblog
Scroll to Top